| Literature DB >> 25054605 |
Ricardo Prado Golmia, Ayk Helena Barbosa Martins, Morton Scheinberg.
Abstract
Patients with psoriasis and psoriatic arthritis respond to anti-TNF therapy, but not all patients maintain effective response, and some do not respond. In this article, we demonstrate the role of a new pathogenetic pathway to some extent TNF-independent in these patients. Anti-IL12-23 is a new and alternate mode of therapy for patients with recalcitrant response to anti-TNF.Entities:
Mesh：
Substances：
Year: 2014 PMID： 25054605
Source DB: PubMed Journal: Rev Bras Reumatol ISSN： 0482-5004